Orphanet: Suche Krankheit/Gen
x

Suche Forschungsprojekt

* (*) Felder müssen ausgefüllt werden

128 Ergebnis(se)

Sortiert nach

Förderung durch ein IRDiRC-Mitglied = ERN-Mitglied =

Forschungsprojekt(e)

BELGIEN

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

BELGIEN

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FLONAMUC: Epidemiology of the Nasal Flora at the Reference Center for Cystic Fibrosis of Queen Fabiola Children's University Hospital
Hôpital Universitaire des Enfants Reine Fabiola - HUDERF
Service de Pneumologie-Allergologie

BELGIEN

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

MucoSWEATomics New Markers of CFTR Function in Sweat: Value for Diagnosis and Efficacy of Target Therapies
Université Catholique de Louvain (UCL)
Louvain centre for Toxicology and Applied Pharmacology

BELGIEN

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES

Efflux as a mechanism of intrinsic and acquired resistance to antibiotics in Achromobacter xylosoxidans
Cellular and Molecular Pharmacology Unit, Louvain Drug Research Institute, UCL
Cellular and Molecular Pharmacology Unit

BELGIEN

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES

Development of CFTR-stabilizers as therapeutic for cystic fibrosis
Structure et Fonction des Membranes Biologiques
Laboratoire Structure et Fonction des Membranes Biologiques

BELGIEN

OOST-VLAANDEREN
GENT

Developing a personalized approach for antimicrobial susceptibility testing in cystic fibrosis
LPM Pharmaceutical Microbiology, Universiteit Gent
LPM Laboratory of Pharmaceutical Microbiology

BELGIEN

VLAAMS BRABANT
LEUVEN

Development of drug based therapies to target rare mutations causing severe cystic fibrosis
Center for molecular medicine, Division of Molecular Virology and Gene Therapy
Molecular Virology and Gene Therapy

BELGIEN

VLAAMS BRABANT
LEUVEN

Evaluation of CFTR function in cultured organoids from rectal biopsies in patients with Cystic Fibrosis
UZ Leuven - Campus Gasthuisberg
Dienst Kindergeneeskunde/Department of Pediatrics

BELGIEN

VLAAMS BRABANT
LEUVEN

DEUTSCHLAND

Berlin
BERLIN

Förderung durch ein IRDiRC-MitgliedCORD : Collaboration On Rare Diseases
Geschäftsstelle BIH
Berliner Institut für Gesundheitsforschung

FRANKREICH

AUVERGNE-RHONE-ALPES
GRENOBLE

FRANKREICH

AUVERGNE-RHONE-ALPES
GRENOBLE

Muscular function & cystic fibrosis
Université Joseph Fournier
Laboratoire de Recherche Exercice-Santé

FRANKREICH

BOURGOGNE-FRANCHE-COMTE
BESANÇON

FRANKREICH

BRETAGNE
BREST

Study of the involvement of pulmonary neuroendocrine cells in cystic fibrosis
CHU de Brest - Hôpital de la Cavale Blanche
Laboratoire de génétique moléculaire et d'histocompatibilité

FRANKREICH

CENTRE-VAL DE LOIRE
ORLEANS

Cellular and molecular interactions between proteins E3-14.7K / FIP-1 and microtubules in cystic fibrosis
Centre de biophysique moléculaire
Glycobiologie vectorologie et trafic intracellulaire

FRANKREICH

CENTRE-VAL DE LOIRE
TOURS

Induction of neutrophilic traps (NETs) by the inflammation and infectious pulmonary environment of cystic fibrosis
Faculté de pharmacie de Tours
Unité INSERM U618 "Protéases et Vectorisation Pulmonaires"

FRANKREICH

CENTRE-VAL DE LOIRE
TOURS

Identification of ligands of human lung cells and production of vectors derived from HPV to lung targeting in cystic fibrosis
Faculté de pharmacie de Tours
Unité INSERM U618 "Protéases et Vectorisation Pulmonaires"

FRANKREICH

GRAND-EST
REIMS

Does the mutation of the CFTR contributes to the bone fragility in cystic fibrosis?
Université de Reims - UFR des sciences exactes et naturelles
INSERM UMR-S 926 "Interfaces Biomatériaux / Tissus Hôtes"

FRANKREICH

HAUTS-DE-FRANCE
VILLENEUVE D'ASCQ

Regulation and control of the biosynthesis of sialyl Lewisx and 6-sulfo sialyl Lewisx, ligands of Pseudomonas aeruginosa in human bronchial mucosa in cystic fibrosis
Faculté des Sciences et Technologies - Université de Lille
UGSF - Unité de glycobiologie structurale et fonctionnelle

FRANKREICH

HAUTS-DE-FRANCE
VILLENEUVE D'ASCQ

Study of the expression and the glycosylation of DMBT1 by the parietal glycoconjugates (LPS and alginate) of Pseudomonas aeruginosa from patients with cystic fibrosis
Faculté des Sciences et Technologies - Université de Lille
UGSF - Unité de glycobiologie structurale et fonctionnelle

FRANKREICH

ILE-DE-FRANCE
CRÉTEIL

Contribution to the study of the CFTR interactome: dynamics and role of a CFTR-containing complex in inflammation in cystic fibrosis
Faculté de Médecine de Créteil
Equipe "Immunopathologie rénale et immunomodulation en transplantation"

FRANKREICH

ILE-DE-FRANCE
GARCHES

Mycobacterium abscessus - phagocytic cells CFTR-/ - and particular susceptibility of CF patients
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de microbiologie

FRANKREICH

ILE-DE-FRANCE
PARIS

Implementation of non-invasive prenatal diagnosis of rare and severe monogenic diseases
CHU Paris Centre - Hôpital Cochin, Site Cochin
Service de génétique et biologie moléculaires

FRANKREICH

ILE-DE-FRANCE
PARIS

Assessment of perfusion pressures on introduced catheter chamber in adult patients with cystic fibrosis
CHU Paris Centre - Hôpital Cochin, Site Cochin
Service de pneumologie - CRCM

FRANKREICH

ILE-DE-FRANCE
PARIS

Tracheal malformations in cystic fibrosis: fundamental studies and clinical investigation
CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
Service de pneumologie pédiatrique

FRANKREICH

ILE-DE-FRANCE
PARIS

Indications and benefits of nocturnal oxygen therapy in cystic fibrosis
CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
Service de pneumologie pédiatrique

FRANKREICH

ILE-DE-FRANCE
PARIS

Modulation of alveolar macrophage and bronchial epithelial cells function by the antimicrobial/antelastase elafin molecule in cystic fibrosis patients
Faculté de Médecine Paris Diderot Paris 7 - site Bichat
Physiopathologie et Epidémiologie des Maladies respiratoire - INSERM UMR 1152

FRANKREICH

ILE-DE-FRANCE
PARIS

FRANKREICH

ILE-DE-FRANCE
PARIS

NEUPROCF: new diagnostic and prognostic biomarkers in cystic fibrosis (coordination)
Faculté de médecine Paris-Descartes, Site Necker
Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"

FRANKREICH

ILE-DE-FRANCE
PARIS

Genotype-phenotype study of CFTR from a new model of human respiratory epithelium of cystic fibrosis
Faculté de médecine Paris-Descartes, Site Necker
Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"

FRANKREICH

ILE-DE-FRANCE
PARIS

Validation of the assessment of bone mineralization by quantitative computed tomography in patients with cystic fibrosis
Faculté de médecine Paris-Descartes, Site Necker
Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"

FRANKREICH

ILE-DE-FRANCE
PARIS

Virulence of Mycobacterium abscessus: role of surface glycopeptidolipids in cystic fibrosis
Faculté de médecine Paris-Descartes, Site Necker
Analyse génétique de l'enveloppe mycobactérienne

FRANKREICH

ILE-DE-FRANCE
PARIS

Prospective study of the psychopathology of adolescents with cystic fibrosis
Hôpital Necker-Enfants Malades
Unité de pneumo-allergologie pédiatrique

FRANKREICH

ILE-DE-FRANCE
PARIS

Three-dimensional structure modeling of CFTR: predicting the impact of mutations and binding sites of markers / potentiators in cystic fibrosis patients
IMPMC - Institut de Minéralogie et de Physique des Milieux Condensés
Protein Structure Prediction

FRANKREICH

ILE-DE-FRANCE
VERSAILLES

Highlight CNG cation channels (cyclic nucleotide-gated cation channels) in the bronchial epithelium and bronchiolar airways of human with cystic fibrosis or not
Université de Versailles Saint-Quentin
Laboratoire Mécanismes pharmacologiques et moléculaires de l' obstruction bronchique

FRANKREICH

ILE-DE-FRANCE
VILLEJUIF

Förderung durch ein IRDiRC-MitgliedTransition Platforms: Understanding the Expectations of Parents of Young People with Rare Diseases
CLCC Institut Gustave Roussy
Equipe Epidémiologie des radiations, épidémiologie clinique des cancers et survie

FRANKREICH

NOUVELLE AQUITAINE
POITIERS

FRANKREICH

OCCITANIE
MONTPELLIER

Measuring the impact of surgery on nasosinusienne ENT symptoms and sleep quality in patients with cystic fibrosis
CHU de Montpellier - Hôpital Arnaud de Villeneuve
Service des maladies respiratoires

FRANKREICH

OCCITANIE
MONTPELLIER

DNA glycomimetics to prevent the adherence of Pseudomonas aeruginosa - impact in cystic fibrosis
Faculté de Pharmacie
Département oligonucléotides modifiés

FRANKREICH

OCCITANIE
MONTPELLIER

Study of CFTR gene's transcriptional regulation in cystic fibrosis
IURC - Institut Universitaire de Recherche Clinique
Laboratoire de génétique moléculaire

FRANKREICH

OCCITANIE
MONTPELLIER

FRANKREICH

OCCITANIE
MONTPELLIER

Identification of new regulatory actors in the noncoding regions of CFTR gene: the microRNA and cystic fibrosis
IURC - Institut Universitaire de Recherche Clinique
Laboratoire de génétique moléculaire

FRANKREICH

OCCITANIE
MONTPELLIER

Study of virulence factor MGTC and its inhibition by a natural peptide in Pseudomonas aeruginosa and in non-tuberculous mycobacteria - impact in cystic fibrosis
Université Montpellier II
Laboratoire de dynamique des interactions membranaires normales et pathologiques - Case 107

FRANKREICH

OCCITANIE
TOULOUSE

Effect of CFTR on the intra-enterocyte cholesterol in patients with cystic fibrosis
CHU de Toulouse - Hôpital Purpan
Département lipoprotéines et médiateurs lipidiques

FRANKREICH

PAYS DE LA LOIRE
NANTES

CFTR gene expression in the pulmonary epithelium by targeted gene transfer in cystic fibrosis
Faculté de médecine de Nantes
Physiopathologie et pharmacologie cellulaire et moléculaire

FRANKREICH

PAYS DE LA LOIRE
NANTES

Reduced lung inflammation in cystic fibrosis by inhibiting the expression of key genes by RNA interference
Faculté de médecine de Nantes
Physiopathologie et pharmacologie cellulaire et moléculaire

IRLAND

County Cork
CORK

Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Cork University Hospital
Department of Respiratory Medicine

IRLAND

County Dublin
DUBLIN

The natural history of cystic fibrosis liver disease - refining the phenotype
Children's Health Ireland @ Crumlin
Gastroenterology Department

IRLAND

County Dublin
DUBLIN

C-FORMS: Children's Follow up Orkambi Real world MBV Study
Children's Health Ireland @ Crumlin
Gastroenterology Department

IRLAND

County Dublin
DUBLIN

SHIELD CF - The Study of Host Immunity and Early Lung Disease in Cystic Fibrosis
Children's Health Ireland @ Crumlin
Respirology Department

IRLAND

County Dublin
DUBLIN

C-FORMS: Children's Follow up Orkambi Real world MBV Study
Children's Health Ireland @ Crumlin
Respirology Department

IRLAND

County Dublin
DUBLIN

PALM Study: Protease Activity:Lung Measurement in Children with Cystic Fibrosis
Children's Health Ireland @ Crumlin
Respirology Department

IRLAND

County Dublin
DUBLIN

Cystic Fibrosis Urinary Biomarker Study (CUBS Study)
Children's Health Ireland @ Crumlin
Respirology Department

IRLAND

County Dublin
DUBLIN

Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Children's Health Ireland @ Crumlin
Respirology Department

IRLAND

County Dublin
DUBLIN

IRLAND

County Dublin
DUBLIN

The Role of Exosomes in Cystic Fibrosis Airway Pathogenesis (RECAP)
Children's Health Ireland @ Crumlin
Respirology Department

IRLAND

County Dublin
DUBLIN

Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Children's Health Ireland @ Temple Street
Cystic Fibrosis Clinic

IRLAND

County Dublin
DUBLIN

SHIELD CF - The Study of Host Immunity and Early Lung Disease in Cystic Fibrosis
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre

IRLAND

County Dublin
DUBLIN

C-FORMS: Children's Follow up Orkambi Real world MBV Study
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre

IRLAND

County Dublin
DUBLIN

Cystic Fibrosis Urinary Biomarker Study (CUBS Study)
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre

IRLAND

County Dublin
DUBLIN

Predicting Response in Disease outcomes in CF using iPSCs for new CFTR Therapies (PREDiCT)
Children's Health Ireland @Tallaght
Specialist Cystic Fibrosis Centre

IRLAND

County Dublin
DUBLIN

The Role of Exercise in the Management of Cystic Fibrosis
Dublin City University
MedEx Research Laboratory

IRLAND

County Dublin
DUBLIN

The natural history of cystic fibrosis liver disease - refining the phenotype
The Catherine McAuley Education & Research Centre
UCD School of Medicine

IRLAND

County Limerick
LIMERICK

SHIELD CF - The Study of Host Immunity and Early Lung Disease in Cystic Fibrosis
University Hospital Limerick
Cystic Fibrosis Clinic

IRLAND

County Limerick
LIMERICK

C-FORMS: Children's Follow up Orkambi Real world MBV Study
University Hospital Limerick
Cystic Fibrosis Clinic

IRLAND

County Limerick
LIMERICK

Cystic Fibrosis Urinary Biomarker Study (CUBS Study)
University Hospital Limerick
Cystic Fibrosis Clinic

IRLAND

County Limerick
LIMERICK

ITALIEN

LAZIO
ROMA

Anti-inflammatory therapy with dexamethasone slow release in the control of lung inflammation in patients with Cystic Fibrosis
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Epatologia, Gastroenterologia e Nutrizione

ITALIEN

LAZIO
ROMA

Förderung durch ein IRDiRC-MitgliedItalian National Cystic Fibrosis Patient's Registry
ISS - Istituto Superiore di Sanità
Centro Nazionale Malattie Rare

ITALIEN

LAZIO
ROMA

Förderung durch ein IRDiRC-MitgliedImproving quality standards in Italian laboratories performing genetic testing for rare diseases
ISS - Istituto Superiore di Sanità
Centro Nazionale Malattie Rare

ITALIEN

LOMBARDIA
MILANO

Förderung durch ein IRDiRC-MitgliedRescueCFTRpreclinic: Cysteamine for the treatment of cystic fibrosis: a translational research project - IT
IRCCS Ospedale San Raffaele
Centro di Genomica, Bioinformatica e Biostatistica - Unità di Genetica Umana e Molecolare

KANADA

Colombie-Britannique
VANCOUVER

Mechanisms of Hyperinfammation in Cystic Fibrosis
Centre for Microbial Diseases and Immunity Research

KANADA

Nouvelle-Écosse
HALIFAX

Förderung durch ein IRDiRC-MitgliedFunctional Architecture of the CFTR Chloride Channel
Dalhousie University
Department of Physiology & Biophysics

KANADA

Nouvelle-Écosse
HALIFAX

Regulation of CFTR membrane stability and function by VIP
Dalhousie University
Department of Physiology & Biophysics

KANADA

Ontario
TORONTO

Förderung durch ein IRDiRC-MitgliedEvaluating the Mechanism of Action of Small Molecule Modulators of CFTR
Hospital for Sick Children, Research Institute

KANADA

Ontario
TORONTO

Pathophysiology of Cystic Fibrosis Lung Disease
Hospital for Sick Children, Research Institute
Paediatric Laboratory Medicine

KANADA

Ontario
TORONTO

Förderung durch ein IRDiRC-MitgliedEnsuring effective newborn screening: The case of cystic fibrosis
University of Toronto
Institute of Health Policy, Management and Evaluation

KANADA

Québec
MONTRÉAL

Screening for abnormalities related to glucose tolerance secondary to cystic fibrosis
Institut de recherches cliniques de Montréal
Plateforme de recherche en obésité, métabolisme et diabète

KANADA

Québec
MONTRÉAL

Förderung durch ein IRDiRC-MitgliedNeutrophilic inflammation in Cystic Fibrosis
Meakins-Christie Laboratories

NORWEGEN

Østlandet
OSLO

Cystic Fibrosis and Fit-to-Fly
Oslo University Hospital, Ullevaal
NSCF - Norsk senter for cystisk fibrose

OSTERREICH

WIEN
WIEN

Lungenmikrobiom als Biomarker für CF (Cystische Fibrose) Exazerbation
Medizinische Universität Wien
Forschungslabor Infektionsbiologie

PORTUGAL

SUL
LISBOA

Elucidating the role of novel CFTR interactors - new mechanisms in membrane protein trafficking.
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit

PORTUGAL

SUL
LISBOA

Diagnosis, Prognosis and Treatment of Cystic Fibrosis
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit

PORTUGAL

SUL
LISBOA

Characterization of ER-quality control for the F508del-CFTR protein: potential therapeutic targets for cystic fibrosis
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit

PORTUGAL

SUL
LISBOA

Identification of Novel Targets Rescuing of F508del-CFTR Traffic: Mechanism of Action
Faculdade de Ciências da Universidade de Lisboa
Membrane Protein Disorders Unit

PORTUGAL

SUL
OEIRAS

Biochemical and Structural Studies of UDP-Glucose Dehydrogenases.
Instituto de Tecnologia Química e Biológica
Unidade de Cristalografia Macromolecular

SCHWEIZ

Suisse Alémanique
BERN

Multiple Breath Washout in Children with Cystic Fibrosis: Transition from a Specialised Tool to Clinical Implementation
Inselspital Universitätsspital
Abteilung für pädiatrische Pneumologie und Allergologie

SCHWEIZ

Suisse Alémanique
BERN

Prospective Surveillance of Lung Development During Childhood, Adolescence and Adulthood in Healthy and Patients With Cystic Fibrosis
Inselspital Universitätsspital
Abteilung für pädiatrische Pneumologie und Allergologie

SCHWEIZ

Suisse Alémanique
BERN

SCHWEIZ

Suisse Romande
GENÈVE

Intercellular signaling in cystic Fibrosis airway innate host defense mechanisms
Centre Médical Universitaire - CMU
Département de physiologie cellulaire et métabolisme

SPANIEN

Cataluña
SABADELL

Förderung durch ein IRDiRC-MitgliedImpact of viral respiratory infection on the gut-lung axis microbiome in cystic fibrosis
Corporación Sanitaria Parc Taulí. Hospital de Sabadell
Servicio de neumología

VEREINIGTE STAATEN

Maryland
BETHESDA

VEREINIGTE STAATEN

Washington
ADDRESS: NOT PROVIDED - US

VEREINIGTES KONIGREICH

Antrim and Newtownabbey
BELFAST

Parameters to Assess Response to Intra-Venous Antibiotic Treatment for Pulmonary Exacerbations in Cystic Fibrosis (PRIVATE)
Queen's University Belfast
School of Medicine, Dentistry and Biomedical Sciences

VEREINIGTES KONIGREICH

Avon
BRISTOL

EUROCARE CF: European coordination action for research in cystic fibrosis (coordination)
University of Bristol
Department of Physiology and Pharmacology

VEREINIGTES KONIGREICH

Greater London
LONDON

Air Pollution and Children With Cystic Fibrosis -GB
Queen Mary University of London Headquarters

VEREINIGTES KONIGREICH

Greater Manchester
MANCHESTER

VEREINIGTES KONIGREICH

Lothian
EDINBURGH

Förderung durch ein IRDiRC-MitgliedInflammation in Cystic Fibrosis Lung Disease: Defining the Role of Calprotectin
Western General Hospital
Edinburgh Cancer Research Centre

VEREINIGTES KONIGREICH

Warwickshire
COVENTRY

FRANKREICH

AUVERGNE-RHONE-ALPES
LA TRONCHE

Förderung durch ein IRDiRC-MitgliedFundamental, genetic and clinical aspects of male infertility caused by severe abnormalities of the sperm flagella
Université Grenoble Alpes (UGA) - Campus santé
Institut Albert Bonniot - INSERM U823

FRANKREICH

ILE-DE-FRANCE
PARIS

Förderung durch ein IRDiRC-MitgliedSTaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FRANKREICH

PAYS DE LA LOIRE
NANTES

Förderung durch ein IRDiRC-MitgliedFROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

JAPAN

JAPAN
TOKYO

Förderung durch ein IRDiRC-MitgliedFormation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development
Research Institute

KANADA

Ontario
TORONTO

VEREINIGTE STAATEN

Washington
ADDRESS: NOT PROVIDED - US

Förderung durch ein IRDiRC-MitgliedA powerful web-based discovery platform for rare disease genetics
Institution: Information not provided - US

Multizentrische Forschungsprojekte